Verition Fund Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Verition Fund Management's MRK Position: Q2 2026 in Review
Verition Fund Management increased its Merck (MRK) stake by 1,681% in Q2 2026, buying an estimated $5.93M and bringing the position to 53,638 shares worth $6.89M. The position accounts for 0.04% of the portfolio, ranked #509.
Verition Fund Management first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $17.5M in Q1 2019. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Verition Fund Management held 53,638 shares of Merck worth $6.89M as of Q2 2026.
- Verition Fund Management bought 50,627 Merck shares in Q2 2026, an estimated $5.93M.
- Merck made up 0.04% of Verition Fund Management's portfolio in Q2 2026, its #509 holding.
- Verition Fund Management first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
- Verition Fund Management's Merck position peaked at $17.5M in Q1 2019.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.